terfenadine has been researched along with Prosthesis Durability in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pighi, M | 1 |
| Lunardi, M | 1 |
| Ribichini, FL | 1 |
| Sathananthan, J | 1 |
| Fraser, R | 1 |
| Kütting, M | 1 |
| Hensey, M | 1 |
| Landes, U | 1 |
| Alkhodair, A | 1 |
| Sedaghat, A | 1 |
| Blanke, P | 1 |
| Toggweiler, S | 1 |
| Leipsic, J | 1 |
| Søndergaard, L | 1 |
| Wood, D | 1 |
| Webb, JG | 1 |
2 other studies available for terfenadine and Prosthesis Durability
| Article | Year |
|---|---|
NVT ALLEGRA transcatheter heart valve for valve-in-valve procedures in failing surgical aortic bioprostheses: let us wait and see.
Topics: Aortic Valve; Aortic Valve Stenosis; Bioprosthesis; Cardiac Catheterization; Heart Valve Prosthesis; | 2019 |
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions.
Topics: Aortic Valve; Bioprosthesis; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemodynami | 2020 |